Patent details

EP2440177 Title: PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION OF A BCL-2 FAMILY INHIBITOR

Basic Information

Publication number:
EP2440177
PCT Application Number:
PCT/IB/2010/001659
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP107428757
PCT Publication Number:
WO/2010/143074
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION OF A BCL-2 FAMILY INHIBITOR
French Title of Invention:
FORME POSOLOGIQUE PHARMACEUTIQUE POUR L'ADMINISTRATION ORALE D'UN INHIBITEUR DE LA FAMILLE DE BCL-2
German Title of Invention:
PHARMAZEUTISCHE DOSIERUNGSFORM ZUR ORALEN VERABREICHUNG EINES HEMMERS DER BCL-2-FAMILIE
SPC Number:

Dates

Filing date:
08/06/2010
Grant date:
16/09/2015
EP Publication Date:
16/09/2015
PCT Publication Date:
16/12/2010
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
18/04/2012
EP B1 Publication Date:
16/09/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
08/06/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
31/01/2018
 
 

Name:
AbbVie Deutschland GmbH & Co. KG
Address:
Mainzer Strasse 81, 65189, Wiesbaden, Germany (DE)

History of Owners

From:
08/06/2010
To:
31/01/2018

Name:
Abbott GmbH & Co. KG
Address:
Max-Planck-Ring 2, 65205 Wiesbaden, Germany (DE)

Inventor

1

Name:
STEIGER Norbert
Address:
Germany (DE)

2

Name:
KOSTELAC Drazen
Address:
Germany (DE)

3

Name:
PACKHAEUSER Claudia
Address:
Germany (DE)

4

Name:
LIEPOLD Bernd
Address:
Germany (DE)

5

Name:
KNOBLOCH Martin
Address:
Germany (DE)

Priority

Priority Number:
185130 P
Priority Date:
08/06/2009
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 9/00;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2018/04
Publication date:
23/03/2018
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20180000025A
Date Registered:
31/01/2018
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
Office FREYLINGER S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
AbbVie Deutschland GmbH & Co. KG
Address:
Mainzer Strasse 81, 65189, Wiesbaden, Germany (DE)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
30/06/2025
Annual Fee Number:
16
Annual Fee Amount:
230 Euro
Expected Payer:
Last Annual Fee Payment Date:
14/05/2024
Last Annual Fee Paid Number:
15
Last Annual Fee Paid Amount:
213 Euro
Payer:
MASTER DATA CENTER INC (ex Clarivate Analytics)
Filing date Document type Number of pages
31/01/2018 Request For Change 4
26/02/2018 Outgoing Correspondence 1